Published in Methods Mol Biol on January 01, 2010
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet (2012) 1.33
High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families. Fam Cancer (2014) 0.76
Microsatellite instability of gastric cancer and precancerous lesions. Int J Clin Exp Med (2015) 0.75
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol (2006) 1.40
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer (2012) 1.27
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res (2004) 0.93
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer (2010) 0.88
Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension (2012) 0.82
Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A (2013) 0.82
Genomic alterations as mediators of miRNA dysregulation in ovarian cancer. Genes Chromosomes Cancer (2014) 0.80
Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines. Cancer Immunol Res (2014) 0.78
Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. J Breath Res (2016) 0.76
Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors. Horm Cancer (2015) 0.75
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes. Expert Opin Med Diagn (2007) 0.75